key: cord-0959515-atqci08p
authors: Tsai, Shao-Chen; Lee, Wen-Sen; Chen, Po-Yueh; Hung, Shih-Han
title: Real World clinical performance of SARS-CoV-2 rapid antigen tests in suspected COVID-19 cases in Taiwan
date: 2021-07-13
journal: J Formos Med Assoc
DOI: 10.1016/j.jfma.2021.07.011
sha: f0fa31ebc6151695f9d94759cfccd0bcb48f329e
doc_id: 959515
cord_uid: atqci08p

nan

To address this concern, we evaluated the real-world performance of SARS-CoV-2 rapid antigen tests in suspected COVID-19 cases during the outbreak in Taiwan those testing negative are free to return home. The use of rapid antigen testing as a "rule-out" test is carried out in many countries, and its role should be carefully determined based on the disease prevalence.4 As exposure to COVID-19 will likely be unavoidable in the following daily medical practice, the need for a cost-effective testing method will be crucial. Under the condition of low disease prevalence, the rapid antigen test provides means to significantly save time and cost and facilitate prompt medical decision-making by rapidly identifying low-risk individuals. 

Taiwan Centers for Disease Control. CECC raises epidemic warning to Level 2 and implements related restrictions and measures, effective from May 11 to June 8, in response to increased risk of community

Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values

Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses-Wisconsin

Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection